These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Lysophospholipids induce the nucleation and extension of beta2-microglobulin-related amyloid fibrils at a neutral pH. Ookoshi T; Hasegawa K; Ohhashi Y; Kimura H; Takahashi N; Yoshida H; Miyazaki R; Goto Y; Naiki H Nephrol Dial Transplant; 2008 Oct; 23(10):3247-55. PubMed ID: 18467373 [TBL] [Abstract][Full Text] [Related]
30. Role of the C-terminal 28 residues of beta2-microglobulin in amyloid fibril formation. Ivanova MI; Gingery M; Whitson LJ; Eisenberg D Biochemistry; 2003 Nov; 42(46):13536-40. PubMed ID: 14622000 [TBL] [Abstract][Full Text] [Related]
31. Disease-relevant β Wilkinson M; Gallardo RU; Martinez RM; Guthertz N; So M; Aubrey LD; Radford SE; Ranson NA Nat Commun; 2023 Mar; 14(1):1190. PubMed ID: 36864041 [TBL] [Abstract][Full Text] [Related]
32. IR spectroscopic analyses of amyloid fibril formation of β2-microglobulin using a simplified procedure for its in vitro generation at neutral pH. Fabian H; Gast K; Laue M; Jetzschmann KJ; Naumann D; Ziegler A; Uchanska-Ziegler B Biophys Chem; 2013 Sep; 179():35-46. PubMed ID: 23727989 [TBL] [Abstract][Full Text] [Related]
33. Growth of beta(2)-microglobulin-related amyloid fibrils by non-esterified fatty acids at a neutral pH. Hasegawa K; Tsutsumi-Yasuhara S; Ookoshi T; Ohhashi Y; Kimura H; Takahashi N; Yoshida H; Miyazaki R; Goto Y; Naiki H Biochem J; 2008 Dec; 416(2):307-15. PubMed ID: 18637792 [TBL] [Abstract][Full Text] [Related]
34. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis. Kazama JJ; Maruyama H; Gejyo F Nephrol Dial Transplant; 2001; 16 Suppl 4():31-5. PubMed ID: 11402095 [TBL] [Abstract][Full Text] [Related]
35. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis. Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180 [TBL] [Abstract][Full Text] [Related]
36. Structure of interacting segments in the growing amyloid fibril of beta2-microglobulin probed with IR spectroscopy. Lu M; Hiramatsu H; Goto Y; Kitagawa T J Mol Biol; 2006 Sep; 362(2):355-64. PubMed ID: 16919295 [TBL] [Abstract][Full Text] [Related]
37. Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin: roles of shear flow, hydrophobic surfaces, and α-crystallin. Mangione PP; Esposito G; Relini A; Raimondi S; Porcari R; Giorgetti S; Corazza A; Fogolari F; Penco A; Goto Y; Lee YH; Yagi H; Cecconi C; Naqvi MM; Gillmore JD; Hawkins PN; Chiti F; Rolandi R; Taylor GW; Pepys MB; Stoppini M; Bellotti V J Biol Chem; 2013 Oct; 288(43):30917-30. PubMed ID: 24014031 [TBL] [Abstract][Full Text] [Related]
38. Extension of A beta2M amyloid fibrils with recombinant human beta2-microglobulin. Yamaguchi I; Hasegawa K; Naiki H; Mitsu T; Matuo Y; Gejyo F Amyloid; 2001 Mar; 8(1):30-40. PubMed ID: 11293823 [TBL] [Abstract][Full Text] [Related]
39. Characterization of β2-microglobulin conformational intermediates associated to different fibrillation conditions. Santambrogio C; Ricagno S; Sobott F; Colombo M; Bolognesi M; Grandori R J Mass Spectrom; 2011 Aug; 46(8):734-41. PubMed ID: 21766392 [TBL] [Abstract][Full Text] [Related]
40. Insights into the role of the beta-2 microglobulin D-strand in amyloid propensity revealed by mass spectrometry. Leney AC; Pashley CL; Scarff CA; Radford SE; Ashcroft AE Mol Biosyst; 2014 Mar; 10(3):412-20. PubMed ID: 24336936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]